Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
21.04
0.52
2.47%
Share Warrants & Outstandings
Total Reserve
-167.80
160.76
-328.56
-204.38%
Shareholder's Funds
-146.24
181.80
-328.04
-180.44%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
161.25
0.00
161.25
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
161.25
0.00
161.25
0.00%
Deferred Tax Assets / Liabilities
0.00
4.49
-4.49
-100.00%
Other Long Term Liabilities
45.00
0.00
45.00
0.00%
Long Term Trade Payables
2.44
0.00
2.44
0.00%
Long Term Provisions
3.06
0.00
3.06
0.00%
Total Non-Current Liabilities
211.75
4.49
207.26
4,616.04%
Current Liabilities
Trade Payables
18.15
18.68
-0.53
-2.84%
Other Current Liabilities
33.63
22.42
11.21
50.00%
Short Term Borrowings
50.96
0.03
50.93
169,766.67%
Short Term Provisions
0.79
5.56
-4.77
-85.79%
Total Current Liabilities
103.53
46.69
56.84
121.74%
Total Liabilities
169.04
232.98
-63.94
-27.44%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.11
51.22
262.89
513.26%
Less: Accumulated Depreciation
168.40
30.57
137.83
450.87%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.70
20.65
125.05
605.57%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.24
0.00
1.24
0.00%
Intangible assets under development
1.85
0.00
1.85
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
18.76
-18.76
-100.00%
Long Term Loans & Advances
9.98
0.72
9.26
1,286.11%
Other Non Current Assets
0.00
1.40
-1.40
-100.00%
Total Non-Current Assets
158.78
41.53
117.25
282.33%
Current Assets Loans & Advances
Current Investments
0.00
110.50
-110.50
-100.00%
Inventories
6.03
17.64
-11.61
-65.82%
Sundry Debtors
0.05
46.83
-46.78
-99.89%
Cash and Bank
0.14
1.68
-1.54
-91.67%
Other Current Assets
0.47
3.90
-3.43
-87.95%
Short Term Loans and Advances
3.56
10.91
-7.35
-67.37%
Total Current Assets
10.26
191.45
-181.19
-94.64%
Net Current Assets (Including Current Investments)
-93.27
144.77
-238.04
-164.43%
Total Current Assets Excluding Current Investments
10.26
80.96
-70.70
-87.33%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
169.04
232.98
-63.94
-27.44%
Contingent Liabilities
8.47
6.65
1.82
27.37%
Total Debt
212.21
0.03
212.18
707,266.67%
Book Value per share (adjusted)
-67.83
86.41
-154.24
-178.50%
Annual - Borrowings
Borrowings 212.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 146.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024






